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Abstract
Nutrition during the perinatal period programs body growth. Growth hormone (GH) secretion
from the pituitary regulates body growth and is controlled by Growth Hormone Releasing
Hormone (GHRH) neurons located in the arcuate nucleus of the hypothalamus. We
observed that dietary restriction during the early postnatal period (i.e. lactation) in mice influ-
ences postnatal growth by permanently altering the development of the somatotropic axis in
the pituitary gland. This alteration may be due to a lack of GHRH signaling during this critical
developmental period. Indeed, underfed pups showed decreased insulin-like growth factor I
(IGF-I) plasma levels, which are associated with lower innervation of the median eminence
by GHRH axons at 10 days of age relative to normally fed pups. IGF-I preferentially stimu-
lated axon elongation of GHRH neurons in in vitro arcuate explant cultures from 7 day-old
normally fed pups. This IGF-I stimulating effect was selective since other arcuate neurons
visualized concomitantly by neurofilament labeling, or AgRP immunochemistry, did not sig-
nificantly respond to IGF-I stimulation. Moreover, GHRH neurons in explants from age-
matched underfed pups lost the capacity to respond to IGF-I stimulation. Molecular analyses
indicated that nutritional restriction was associated with impaired activation of AKT. These
results highlight a role for IGF-I in axon elongation that appears to be cell selective and par-
ticipates in the complex cellular mechanisms that link underfeeding during the early postna-
tal period with programming of the growth trajectory.
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Normal development of both cognitive and somatic functions requires suitable nutrition of
the developing fetus and newborns during the perinatal period [1]. Indeed, insufficient food
supplies during the early postnatal period affect body growth as well as the risk of developing
cardiovascular and metabolic diseases in adulthood. This is in agreement with the develop-
mental origin of health and adult diseases (DOHaD), particularly after intrauterine growth
retardation, which accounts for 5% of births [2]. This programming of adult diseases, which
has been validated in various animal models as well as in human populations [1,3,4,5], further
highlights the importance of mechanisms that link the sensing of nutritional state to a shift in
the developmental trajectory, which is strongly integrated with that of linear growth.
Body growth is controlled by a subset of neurons located in the hypothalamus that regulates
the secretion of Growth Hormone (GH), part of the somatotropic neuro-endocrine axis. The
developmental settings of the somatotropic axis are highly sensitive to early postnatal nutrition
[6,7], suggesting that this subset of hypothalamic neurons is particularly sensitive to nutritional
supply during the perinatal period. Growth programming is also associated with the insulin-
like growth factor I (IGF-I) receptor signaling pathway [7]. Indeed, the permanent growth
delay phenotype resulting from caloric nutritional restriction during lactation [6] can be
genetically mimicked by tissue-specific heterozygous inactivation of the IGF-1 receptor (IGF-
1R) in the central nervous system [7].
GH is secreted from pituitary somatotroph cells under the regulation of two hypothalamic
neurohormones, Growth Hormone Releasing Hormone (GHRH) that stimulates GH secre-
tion, and Somatostatin (SRIH) that inhibits it. Our previous reports suggest that GHRH neu-
rons located in the arcuate nucleus of the hypothalamus may be a key element that influences
programming of the growth trajectory [6,7]. Indeed, we previously observed that the heterozy-
gous invalidation of IGF-1R alters the development of the somatotropic axis, which is associ-
ated with a decrease of GHRH immune-reactivity in the median eminence at 10 days of age
and a specific permanent pituitary hypoplasia of GH-producing somatotroph cells by 20 days
of age. These findings are in agreement with previous studies that highlighted a strong implica-
tion of GHRH in the stimulation of proliferation and differentiation of somatotroph cells
during the early postnatal period through an induction of Pit-1in developing pituitary [8].
Moreover, our previous report indicates that nutritional restriction during lactation in wild
type pups, which decrease circulating levels of IGF-I, similarly induces a permanent pituitary
hypoplasia in somatotroph cells by 20 days of age that is preceded by a transient decrease of
GHRH expression level at 10 days of age. These data indicate a physiological relevance for
IGF-I signalization on the development of the somatotropic axis. Notably, they suggest that the
reprogramming of the somatotropic axis by nutritional restriction foremost involves GHRH
neurons during the first week of life, when the GHRH neurons of the hypothalamus are still
developing, through an underlying mechanism that remains to be deciphered. The current
study aims to highlight how IGF-I acts on GHRH neurons during this critical window.
Developing arcuate neurons may be highly sensitive to IGF-I signaling because the medio-
basal hypothalamus is strongly enriched for IGF-I receptors [9,10]. IGF-I exerts strong prolif-
erative and anti-apoptotic effects [11]. In developing brain, IGF-I signaling is also strongly
associated with cellular morphogenesis: high IGF-I levels in the brain are associated with long
and complex neuronal dendritic arborization [12,13,14]. In addition, IGF-I may also deter-
mine axon fate through the IGF-1Rgc isoform during the early phase of neuronal differentia-
tion [15,16,17]. During the latter phase of neuronal development, IGF-1R signaling is also
implicated in the control of axon guidance in the lateral olfactory bulb [18]. A few reports have
studied the role of IGF-I in axon elongation: Ozdinler et al. have shown that IGF-I can
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stimulate axonal outgrowth in neurons [19], whereas other reports suggest that all neurons do
not display the same sensitivity to IGF-I [18,20]. Here, we determined how undernutrition
during the early postnatal period affects the development of GHRH neurons. We examined
the potential ability of IGF-1 to regulate axonal outgrowth of GHRH neurons, and how it is
controlled by nutrition using in vitro arcuate explant cultures.
Materials & Methods
Animal experiments
In order to measure axon growth of GHRH neurons in vitro, we used the GHRH-eGFP
C57Bl/6J mouse model generated by I.C. Robinson and colleagues [21]. This mouse model
was built with an eGFP DNA sequence merged below the signal peptide of the human
growth hormone in order to drive the eGFP protein in secretory vesicles. This construct was
included in the first intron of the GHRH sequence before micro-injection into fertilized
mouse oocytes. We used the mouse line 39 in which the eGFP expression is not too strong in
the hypothalamus and without ectopic eGFP expression nor any alteration of the GHRH
gene expression [21]. This mouse model has been previously used by various laboratories
[21,22,23,24,25,26]. Mice were housed under standard SOPF conditions in individually ven-
tilated cages at 22˚C with a 12 h light/dark cycle and free access to water and a commercial
rodent diet. Heterozygous GHRH-eGFP males (GHRH-eGFP+/0) maintained under a
C57Bl/6J genetic background were bred with wild type C57Bl/6J females. Pregnant dams
were isolated and housed individually to ensure that pups nutrition during lactation was pro-
vided by only one dam. Nutritional restriction during lactation was achieved for the entire
litter by cross-fostering pups at birth: “normally fed” pups were obtained from a litter size of
six pups per dam and “underfed” pups from a litter size of 10 pups per dam, as described pre-
viously [6,27]. Male and female pups were homogenously balanced in each litter and individ-
ually identified at 4 days of age by toe clipping. At 28 days of age, all animals were randomly
weaned at 6 per cage, independently of their previous diet. From this day, all mice were fed
ad libitum with a standard commercial diet. For body growth measurement, pups body
weight was followed from 10 to 90 days of age. Mice were used at 7, 10, 20 and 90 days of age,
depending of the experiment. Tissues and blood sample were harvested from 10, 20 and 90
days-old mice under deep isoflurane anaesthesia. Brain dedicated to explants cultures were
harvested from seven days-old pups by quick decapitation. The number of mice/litters used
is indicated in results and legends. For experimentations and statistical analyses, all pups
originate from at least three different litters to avoid any maternal bias. All animal proce-
dures were performed in accordance with institutional directives for the care of laboratory
animals and approved by the French national ethics committee 05 Charles Darwin (Project
protocol agreement number Ce5/2012/006).
In Situ Hybridization and Immunohistochemistry
For in situ hybridization, 16 μm frozen sections of brain from 10 day-old male mice were pre-
pared as described previously [21]. Briefly, brain slices were fixed in 4% paraformaldehyde
(PFA) and hybridized with a digoxigenin-labeled (Roche) GHRH-RNA probe [21]. Hybrid-
ized probe was detected with an alkaline phosphatase-conjugated anti-Dig antibody (Table 1)
and NBT/BCIP (Promega) coloration. For brain GHRH immunohistochemistry, the entire
median eminence from paraffin embedded brains from normally fed or underfed P10 male
pups was sliced (7 μm thickness), and one of every ten slices were mounted on slides for the
subsequent innervation analysis. The area of innervation for each slice was determined and
the global ME innervation estimated for each individual (n = 3 normal and 4 underfed). After
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deparaffinization and rehydration, the slices were subjected to heat-induced antigen retrieval
in 10 mM Citrate buffer, pH6. The slices were then incubated with anti-GHRH and anti-
Panendothelial Cell Antigen MECA-32 antibodies (Table 1). Sequential incubation with sec-
ondary antibodies and revelation reagents were then performed: first, slices were incubated
with a biotinylated anti-rabbit secondary antibody (Table 1), followed by amplification with
the ABC Elite kit (Vector) and revealed using DAB (Dako) for the GHRH IHC; secondly, slices
were then incubated with biotinylated anti-rat secondary antibody (Table 1), followed by
amplification with the ABC Elite kit (Vector) and revealed using VIP (Vector) for the MECA-
32 IHC. The slices were mounted and visualized with an Olympus BX43 with DP73 camera.
For the growth hormone (GH) and prolactin (PRL) immunohistochemistry, pituitary glands
from 20 day-old male pups were fixed in 4% PFA and embedded in paraffin. The choice of 20
days of age for pituitary analysis was based on the dynamics of pituitary development, as previ-
ously shown [6,7]. Pituitary glands were sliced (7μm thickness) and were mounted on slides
(three series in parallel). After deparaffinization and rehydration, the first series was incubated
Table 1. Primary and secondary antibodies.
Peptide/Protein
Target
Name of Antibody Manufacturer, Catalog Number, or Name
of Source
Species Raised in
Monoclonal or Polyclonal
Dilution
Used
AgRP Agouti-Related Protein (AGRP) (82–131) Amide
(Mouse) Antibody
Phoenix Pharmaceuticals, H-003-57 Rabbit, polyclonal 1/ 500
Akt Akt (pan) (C67E7) Rabbit mAb (HRP Conjugate) Cell Signaling Technology, #8596 Rabbit, monoclonal 1/ 2000
Chicken IgY Goat Anti-Chicken IgY H&L (DyLight 594) Abcam, ab96949 Goat, polyclonal 1/ 400
Digoxigenin Anti-Digoxigenin-AP, Fab fragments ROCHE, 11093274910 Sheep, polyclonal 1/ 2000
Erk1/2 p44/42 MAPK (Erk1/2) (137F5) Rabbi mAb Cell Signaling Technology, #4695 Rabbit, monoclonal 1/ 1000
GFP Anti-GFP antibody Abcam, ab6556 Rabbit, polyclonal 1/1000
GH Rabbit antiserum to rat growth hormone for
immunocytochemistry
National institute of diabetes & digestive &
kidney diseases (NIDDK), AFP5641801
Rabbit, polyclonal 1/20000
GHRH Anti-VC-15 Proteogenix, home made Rabbit, polyclonal 1/1000
IGF-1R IGF-1 Receptor β Antibody Cell Signaling Technology, #3027 Rabbit, polyclonal 1/ 1000
MECA-32 Purified Rat Anti-Mouse Panendothelial Cell Antigen
MECA-32
BD Pharmingen, 553849 Rat, monoclonal 1/500
Mek1 Polyclonal Anti- Dual specificity mitogen-activated
protein kinase kinase 1, MAP2K1
Boster Biological Technology, PA1376 Rabbit, polyclonal 1/ 3000
Neurofilament Anti-160 kD Neurofilament Medium anibody Abcam, ab72998 Chicken, polyclonal 1/1000
Phospho Akt Phospho-Akt (Ser473) (D9E) XP Rabbit mAb Cell Signaling Technology, #4060 Rabbit, monoclonal 1/ 2000
Phospho Erk1/2 Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)
(D13.14.4E) XP Rabbit mAb
Cell Signaling Technology, #4370 Rabbit, monoclonal 1/ 2000
Phospho IGF-1R Phospho-IGF-I Receptor β (Tyr1135/1136)/Insulin
Receptor β (Tyr1150/1151) (19H7) Rabbit mAb
Cell Signaling Technology, #3024 Rabbit, monoclonal 1/ 500
Phospho Mek1 Anti-Mek1 (phospho S298) antibody [EPR3338] Abcam, ab96379 Rabbit, monoclonal 1/ 3000
PRL Rabbit antiserum to rat Prolactin for
immunocytochemistry
National institute of diabetes & digestive &
kidney diseases (NIDDK), AFP5641801
Rabbit, polyclonal 1/40000
Rabbit IgG Biotinylated anti-rabbit IgG (H+L) Vector Laboratories, BA-1000 Goat, polyclonal 1/200
Rabbit IgG Donkey Anti-Rabbit IgG H&L (DyLight 550)
preadsorbed
Abcam, ab98499 Donkey, polyclonal 1/ 400
Rabbit IgG Goat Anti-Rabbit IgG H&L (DyLight 488) Abcam, ab96883 Goat, polyclonal 1/ 400
Rabbit IgG Anti-Rabbit IgG (whole molecule)-Peroxidase Sigma-Aldrich, A0545 Goat, polyclonal 1/ 20000
Rat IgG Biotinylated anti-rat IgG (H+L) Vector Laboratories, BA-4001 Rabbit, polyclonal 1/200
List of primaries and secondaries antibodies used for immunohistochemistry and western blot experiments with manufacturers’ references and dilutions
used.
doi:10.1371/journal.pone.0170083.t001
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with a rabbit anti-GH antibody and the second one with a rabbit anti-PRL antibody (see
Table 1), followed by incubation with Dylight-549 donkey anti-rabbit IgG for both (Table 1).
The density of somatotrophs cells was measured with the area of GH labeling in three identical
fields (250x250μm) per picture, with 5–11 pictures per individual (n = 3 normal and 4 under-
fed) acquired with fluorescent microscope under identical conditions. The same approach was
performed for lactotrophs cells (PRL) density measurement. All slides were mounted and then
visualized with an Olympus BX612 fluorescence microscope and DP71 CCD camera under
identical acquisition conditions.
Arcuate explant culture experiments
For explants culture experiments, brain was harvested from 7 days old normally or underfed
pups after rapid decapitation. Since a minimum amount of explants is required for the quality
of explants cultures, brain from both males and females were pooled before to be processed all
together. Thus, although females are less sensitive to nutritional restriction than males, which
may dampen the effects observed, arcuate nucleus explants were harvested from pups of both
sexes to obtain a sufficient amount of material from each litter. Brain expression of eGFP was
directly verified at the median eminence level with inverted fluorescent microscope (Evos Cell
Imaging, Evos). Organotypic slices were prepared and then cultured for 48 h as described pre-
viously [28]. Briefly, 300 μm brain slices were incubated on culture membranes (Whatmann)
in MEM Medium (Life technologies) supplemented with 10% FCS, 0.5% glucose, and 1% peni-
cillin/streptomycin. Arcuate nuclei were then microdissected and cultured in neurobasal
medium (Life technologies) supplemented with methylcellulose, B-27 supplement (B-27, Life
Technologies), glucose, L-glutamine, and penicillin/streptomycin (Life technologies). Of note,
the B27 supplement contains insulin for neuron survival at a final concentration of 58 nM,
according to our determinations (Access Ultrasensitive Insulin kit #33410 on an Access 2 auto-
mate, Beckman-Coulter). Cultures were performed in four wells plates, allowing one control
and three treated conditions for each experiment. Each well was filled with eight explants. One
plate could be filled from one normally fed litter and two plates could be filled from one under-
fed litter. Explants experiments with normally fed or underfed pups were conducted sequen-
tially, depending the production of mice. After 24 h in culture, the explants were treated with
100 ng/ml IGF-1 (13.2 nM, R&D systems) alone or in combination with 1 μM OSI-906 (Linsi-
tinib, Selleckchem) for another 24 h. The explants were then fixed for 30 min in 4% PFA and
subjected to immunohistochemistry using primary antibodies directed against neurofilament,
GFP, AgRP, IGF-IR, and their corresponding secondary antibodies (See Table 1). Neurofila-
ments and AgRPs were visualized under a 4X objective, and GFP under a 10X objective since
these axons were smaller, using an Olympus BX612 fluorescence microscope and DP71 CCD
camera.
For the analysis of axon length, the NeuronJ plugin of ImageJ software was used, as previ-
ously described [29]. Briefly, the length of a maximum of 40 axons (mean 24.1 ± 1.5 axons) for
both normal and underfed was measured for each explants. The global axon growth for each
condition was calculated as the mean of the eight quantified explants. The global axon growth
for the three treated conditions were normalized against their respective controls (basal condi-
tion) for each plate due to the variability of the explant cultures. Since pups were pooled for
the explants culture, each plate was considered as one single experiment (n = 1) for statistical
analyses, and data are presented as the mean of relative axon growth calculated from various
experiments (n = 6–9 experiment depending of the test, the number is given in results and leg-
ends). Globally, a total of 14 litters of normally fed and 20 litters of underfed pups were used
for explants cultures.
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Biochemical analysis
Plasma IGF-1 levels were determined from 10 and 90 days old mice using the Mouse/Rat IGF-I
(Mediagnost) ELISA kit according to the manufacturer’s instructions. IGF-I/IGFBP complexes
are dissociated during this assay and the IGFBPs are saturated with IGF-2, thus allowing the
measurement of total circulating IGF-I (spectrophotometer TECAN, GENios Pro). For West-
ern blot analysis, micro-dissected arcuate nuclei from one litter of 7 day-old pups (both sexes)
normally fed or underfed (n = 4–6 litters per group) were recovered in neurobasal medium sup-
plemented with B-27 minus insulin, for 2 h in a separate set of experiments. Arcuate nuclei
explants were stimulated with IGF-1 (100ng/ml) or control medium for 15 min. Proteins of
stimulated and un-stimulated explants were then extracted as previously described [30]. For the
cytosolic fraction, samples were homogenized in a hypertonic buffer consisting of 10 mM
HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, and 0.1 mM EGTA, containing a cocktail of both
protease and phosphatase inhibitors (Roche). After 15 min of incubation on ice, 6.3μl of 1%NP-
40 per 100 μl buffers was added, the samples vortexed briefly, and centrifuged at 5000xg for 1
min at 4˚C. The resulting supernatant, enriched for the cytosolic fraction, was transferred to a
new tube for analysis by Western blot. The pellet was resuspended in a second buffer consisting
of 20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, and 1 mM EGTA. The suspension was
shaken for 15 min at 4˚C and centrifuged at 13000xg for 5 min at 4˚C. The pellet, enriched in
membranous proteins, was resuspended in 150μL PBS. The cytosolic fraction was concentrated
using the Centrifugal Filter Units Amicon Ultra kit (Millipore). The protein concentration of
all fractions was then determined by nanodrop. For each sample, 10 μg of cytoplasmic proteins
(AKT, MEK, ERK) or 7 μg of membrane proteins (IGF-1R) were separated on NuPAGE Bis-
Tris (4–12%) gels (Life technologies) and transferred to PVDF membranes. The membranes
were then incubated with primary antibodies against phospho-ERK1/2 (p-ERK1/2), ERK1/2,
phospho-MAP2K1 (p-MEK1), MAP2K1 (MEK1), phospho-AKT (p-AKT), AKT, Actin, phos-
pho-IGF-1R (p-IGF-1R), and IGF-1R, using an anti-rabbit HRP-IgG as a secondary antibody
(Table 1). The membranes were then revealed with SuperSignal West Pico or Femto Chemilu-
minescent Substrate (37080, 34095, Thermo Scientific) using a high sensitivity, cooled charge-
coupled device (CCD) 6 Mpx camera on a ChemiDoc Touch Imaging System (Biorad).
Measurement of gene expression
Gene expression was determined as described previously [6,7]. Briefly, total RNA from the
pituitary gland of adult male mice was extracted using the silica membrane method according
to the manufacturer’s instructions (NucleoSpin RNA II, Macherey-Nagel). Total RNA from
the pituitary gland of 10-day-old mice was extracted using the phenol-chloroform method
(RNAble, Eurobio). This method was used for 10 days-old pups’ pituitary since silica mem-
branes method does not allow RNA isolation from such small quantities. A total of 1 μg of
RNA was reverse transcribed using random hexamers, RNAse inhibitor, and RevertAid H
Minus Reverse Transcriptase (Fermentas). Real time PCR was performed in duplicate with 6
ng of cDNA on an Applied Biosystem 7300 PCR System. The primers used were GH (Fwd
TCACTGCTTGGCAATGGCTA,Rv ACAGACTGGACAAGGGCATG), and Pit-1 (Fwd CACGGCTC
AGAATTCAGTCA, Rv CTGATGGTTGTCCTCCGTTT). The abundance of mRNA was measured
using the standard curve method and normalized against the housekeeping gene H3f3b (Fwd
CCAGAAATCGACTGAGCTGCTCAT, Rv GCTGCACTTTGAAACCTCAAGTCG).
Statistical analysis
All data are presented as the mean ± SEM. Comparisons between two groups were performed
using the non-parametric test Mann Whitney and the growth curve was analyzed by repeated
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measures Two-way ANOVA. For explant cultures, results from dual immunohistochemistry
(IHC) experiments (e.g. NF/GFP) were analyzed by two-way ANOVA with Bonferroni correc-
tion for multiple comparisons, and the results of singular IHC (AgRP) were analyzed by one-
way ANOVA with Newman Keuls’ multiple comparison test. Statistically non significant
results were abbreviated “NS” in text. Statistically significant results are marked with asterisks,
 p< 0.05;  p< 0.01;  p< 0.001.
Results
Underfeeding during lactation results in permanent growth delay and
reduced secretion of growth hormone
GHRH-eGFP+/0 C57Bl6/J males were mated with wild type C57Bl6/J females. We restricted
nutrition during lactation (P1–P16) in a modest and transient manner [Kappeler, 2009 #9] by
increasing the litter size of C57Bl6/J dams the day of birth from six (“normal”) to 10 (“under-
fed”) pups. Normal and underfed pups were raised in parallel and the effects of this nutritional
restriction on body growth were assessed. Males from underfed (large) litters showed a delay
of postnatal growth that persisted into adulthood (Fig 1A). Females littermates exhibit a lighter
impact of under-nutrition and were not studied further (see S1 Fig). Three month-old male
adult mice subjected to nutritional restriction during lactation had lower circulating IGF-I
plasma levels than mice from normal litters (Fig 1B). This was associated with lower pituitary
growth hormone (GH) mRNA levels (Fig 1C) and permanent pituitary hypoplasia of GH-
secreting somatotroph cells from 20 days of age (Fig 1D), as we previously showed in adults
[6,7]. These modifications are associated with a non significant decrease of GHRH receptor
(GHRH-R) and Pit-1 gene expression in 3 month-old male mice (S2 Fig). The somatotrophs
hypoplasia seems specific since lactotroph cells that originate from the same precursor as
somatotrophs ones do not present any decrease in same animals and even tend to be increased
(non significant, see S3 Fig).
The low activity of the somatotropic axis in pups from underfed litters suggests alterations
in hypothalamus-pituitary development during the early postnatal period [6,7]. In agreement,
underfed 10 day-old male pups displayed decreased circulating levels of IGF-I (Fig 1E) and
lower body weight (Normal: 4.98 ± 0.16 vs Underfed: 4.59 ± 0.08; n = 23–24; t-test: p< 0.05),
as well as lower expression of the somatotroph-differentiating factor Pit-1 in the pituitary
gland (Fig 1F). This was associated with a non-significant decrease of GHRH-R (p = 0.17; Fig
1G) and of GH (p = 0.07; Fig 1H) expression levels. The decrease of Pit-1 in the pituitary
glands of 10 day-old underfed pups suggests a lack of GHRH stimulation, the latter of which
has been shown to stimulate somatotroph cell proliferation through Pit-1 [8]. These findings
suggest that reprogramming of the somatotropic axis induced by nutritional restriction may
involve GHRH neurons which are still developing during this early postnatal period.
Postnatal underfeeding delays innervation of the median eminence by
GHRH neurons
We first determined whether low IGF-I levels in underfed mice were associated with a loss of
GHRH neurons, as IGF-I is very well known for its proliferative and anti-apoptotic actions.
The number of GHRH neurons in normally fed and underfed 10 day-old male pups was simi-
lar by in situ hybridization with a GHRH antisense mRNA probe (Fig 2A), suggesting that
food restriction does not alter the ontogeny of GHRH neurons. We thus looked for morpho-
logical modifications of developing GHRH neurons. We observed a lower anti-GHRH immu-
noreactive area in the median eminence (the target of GHRH neurons) of 10 day-old underfed
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male mice than in age-matched normally fed male mice (Fig 2B). This decrease disappeared by
20 days of age as previously shown [7]. These results suggest that innervation of the median
eminence by GHRH neurons may be delayed by under-nutrition, probably due to an alter-
ation of their axonal elongation. This may explain the lower Pit-1 expression levels observed in
pituitary glands in 10 day-old underfed pups.
Fig 1. Underfeeding during the early postnatal period induces a permanent growth delay. Increasing
litter size from 6 (Normally fed) to 10 (Underfed) pups per dam permanently delayed postnatal growth of male
pups, as observed with postnatal body weight gain (n = 23–25 per group) that persisted into adulthood (A).
This was associated with low circulating plasma levels of IGF-I in 3 month-old male mice previously underfed
during lactation (n = 7–9 per group) (B), accompanied by decreased levels of GH mRNA in the pituitary gland
(n = 9 per group) (C). Representative micrograph of GH-producing somatotroph cells (labeled in red by
immunohistochemistry, counterstaining with DAPI) from normally fed and underfed 20 day-old male pups (D,
left and middle panels respectively) suggest a somatotrophs pituitary hypoplasia (D, right panel) (n = 3–4 per
group). This was preceded by lower plasma levels of IGF-1 (n = 8 per group) (E) and decreased expression of
the somatotroph differentiation factor, Pit-1 (n = 5 per group) (F) in 10 day-old underfed male pups. Moreover,
this was associated with a non—significant tendency of decreased expression levels of GHRH receptor
(GHRH-R) (G) (n = 5 per group), and of GH (H) (n = 5–7 per group) in 10 day-old underfed male pups. All data
are presented as the mean ± SEM. Gene expression determinations are normalized against the histone H3
gene (C, F). Comparisons were performed by repeated measure two-way ANOVA analysis (A) or Mann
Whitney analysis (B–F), with * p < 0.05 and *** p < 0.001.
doi:10.1371/journal.pone.0170083.g001
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Data from IHC experiments in brain suggest that GHRH neurons of the arcuate nucleus of
the hypothalamus innervate the adjacent median eminence by forming a dorso-lateral loop
that reaches the median eminence from the posterior part of the brain, making their axons
very difficult to follow in vivo (E.M. & L.K., personal communication). We thus applied an ex
vivo approach on isolated and in vitro cultivated explants of the arcuate nucleus from normally
fed mice to further examine the role of IGF-I in the elongation of axons of these hypothalamic
neurons [28,31]. IGF-I is virtually expressed by all cells and the immunohistochemistry of
arcuate explants isolated from the brains of normally fed GHRH-eGFP pups showed that the
IGF-1R seem to be concentrated in the distal part of growing GHRH axons (Fig 2C), suggest-
ing that IGF-I may regulate axonal elongation in arcuate neurons.
IGF-I preferentially stimulates axon growth in GHRH arcuate neurons
Arcuate nucleus explants were micro-dissected from 7 day-old GHRH-eGFP pups of both
sexes. Since a minimum amount of explants is required for the quality of explants cultures,
brain from both males and females were pooled before to be processed all together. Thus,
although females are less sensitive to nutritional restriction than males, which may dampen
the effects observed, arcuate nucleus explants were harvested from pups of both sexes to obtain
a sufficient amount of material from each litter. In unstimulated (Control condition) explant
cultures, the axons of GHRH neurons (labeled with eGFP IHC) were shorter than those of
total arcuate neurons labeled with neurofilament (NF) (Control-GHRH: 420 ± 41 μm vs. Con-
trol-NF: 600 ± 58 μm, n = 5 and 6 experiments per group, respectively, p< 0.05).
In explant cultures treated with IGF-I (13.2 nM) for 24 h, axon growth in NF-labeled arcu-
ate neurons was not significantly modified (IGF-I-NF: 662 ± 61 μm vs. Control-NF: 600 ± 58
μm, n = 6 experiments per group, 1.11 ± 0.04 fold, Non Significant: NS; Fig 3A and 3B). In
Fig 2. The development of GHRH neurons is altered in response to underfeeding. The numbers of GHRH neurons in the arcuate
nucleus of the hypothalamus was estimated by in situ hybridization in 10 day-old normally fed or underfed male pups (n = 3 per group)
(A). Concomitantly, the area of innervation of the median eminence (highlighted with the arrow) by axons of GHRH neurons was lower in
10 day-old underfed male pups (n = 4 per group) (B). Illustrative immunohistochemistry from in vitro cultured arcuate nucleus explants
from 7 day-old normally fed pups show that IGF-1R (in red, middle panel) is preferentially enriched in the distal part of growing GHRH
axon (in green, left panel). Merged picture is in the right panel (C). Data are presented as the mean ± SEM. All Comparisons were
performed using Mann Whitney analysis, with *: p < 0.05.
doi:10.1371/journal.pone.0170083.g002
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contrast, axonal growth of GHRH neurons in the same explants was significantly stimulated
by IGF-I (IGF-I-GHRH: 498±68 μm vs. Control-GHRH: 420±41 μm, n = 5 experiments per
group, 1.25 ± 0.06 fold, p< 0.01; Fig 3A and 3B). We used the IGF-1R inhibitor OSI-906 (Lin-
sitinib) [32] alone, or in combination with IGF-I, to confirm that axon growth was specifically
stimulated by IGF-I. Indeed, inhibition of the IGF-1R impaired axon growth in GHRH
(IGF-I/OSI-GHRH: 0.9 ± 0.10 fold vs. IGF-I-GHRH: 1.25 ± 0.06 fold, n = 4–5 experiments per
group, p< 0.0001; Fig 3B), but curiously also in NF neurons (IGF-I/OSI-NF: 0.83 ± 0.04 fold
vs. IGF-I-NF: 1.16 ± 0.02 fold, n = 5 experiments per group, p< 0.0001). Similar results were
obtained using a second IGF-1R inhibitor, picropodophyllotoxin (PPP; data not shown). The
diminution of axonal growth in NF+ neurons by OSI may be due to the requirement of IGF-I
and insulin signaling for neuron survival (insulin is a crucial component of the B27 supple-
ment of the cell culture media for neuron survival, measured at 58 nM), which also associates
with the positive basal axon growth.
The fact that IGF-I significantly stimulated axon growth in GHRH, whereas it did not
in NF+ axons, suggests a cell-selective effect. This was further investigated in another
Fig 3. IGF-I stimulates axon growth of GHRH neurons in arcuate nucleus explants. Illustrative micrograph of in vitro cultured
explants of arcuate nuclei of hypothalamus micro-dissected from 7 day-old normally fed GHRH-eGFP+ pups of both sexes are shown (A)
in basal condition, under IGF-I stimulation or in presence of OSI-906 inhibitor (alone or in combination). Axons from whole arcuate (NF)
and GHRH neurons are labeled by a dual-IHC for neurofilament (NF, top panels in red) and eGFP (GHRH-eGFP, lower panels in green),
respectively. Quantification of relative axon growth stimulated by IGF-I and/or its inhibitor OSI-906 (OSI) in 24 h for NF (plain bars) and
GHRH-eGFP (GHRH, dashed bars) are presented (B). In a separated set of experiment, a similar experiment was performed on NPY/
AgRP neurons labeled by IHC for AgRP (in orange) (C). The relative axon growth of this other subpopulation of arcuate neurons under
IGF-I stimulation and/or its inhibitor OSI-906 (OSI) is presented (D). Data are presented as the mean ± SEM calculated from n = 5–6 (B)
and n = 4 (D) experiments per group, respectively (see results section for details). Results were compared using a two-way ANOVA
analysis with the Bonferonni post-test (B) or one-way ANOVA analysis with the Newman Keuls post-test (C). *: p < 0.05 and **: p < 0.01
for each treatment vs. Control; #: p < 0.05 for GHRH vs. NF.
doi:10.1371/journal.pone.0170083.g003
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subpopulation of arcuate neurons, the orexigenic NPY/AgRP neurons that have been previ-
ously described to respond to the stimulating effect of leptin during the same period of devel-
opment [33,34]. NPY/AgRP neurons were labeled by IHC in a separated set of experiments,
using arcuate explants culture harvested from 7 day-old normally fed pups. IGF-I did not sig-
nificantly stimulate axonal growth of AgRP neurons (AgRP-IGF-I: 559 ± 35μm vs. AgRP-Con-
trol: 497 ± 34μm; 1.13 ± 0.01 fold, n = 4 experiments per group, NS; Fig 3C and 3D) although
OSI906 did inhibit it (Fig 3D). Here again, the diminution of axonal growth in AgRP neurons
by OSI may be due to the inhibition of IGF-I and insulin signaling, which may impact the neu-
rons survival and their basal axon growth. Indeed, insulin is a crucial component of the B27
supplement for neuron survival. Altogether, these results suggest that IGF-I preferentially
stimulates axon elongation of GHRH neurons of the arcuate nucleus from normally fed pups
(IGF-I-GHRH vs. IGF-I-NF: p< 0.01).
Underfeeding alters the response of GHRH neurons to IGF-I
The same experiments as those just described for normally fed pups were performed with
arcuate nucleus explants isolated from 7 day-old underfed GHRH-eGFP pups of both sexes to
further investigate whether axon elongation of GHRH neurons stimulated by IGF-I may be
affected by underfeeding.
In vitro basal axon growth (Control condition) of whole arcuate neurons (NF+) originating
from underfed pups was similar to the growth of those isolated from age-matched normally
fed pups (NF-underfed: 553 ± 26 μm vs. NF-Normally fed: 600 ± 58 μm, n = 9 and 6 experi-
ments per group, respectively, Non Significant: NS). However, in vitro basal axon growth of
GHRH neurons from underfed pups was lower than the growth of GHRH neurons isolated
from normally fed pups (GHRH-underfed: 296 ± 36 μm vs. GHRH-Normally fed: 420 ± 41
μm, n = 7 and 5 experiments per group, respectively, p< 0.05).
Stimulation of explants from underfed GHRH-eGFP pups with IGF-I did not significantly
induce axon growth in NF+ arcuate neurons (NF-IGF-I vs. NF-Control: 1.10 ± 0.03 fold, n = 4
experiments per group, NS; Fig 4A and 4B), similar to the results for normally fed pups. In the
same way, AgRP neurons from underfed pups also did not respond to IGF-I (AgRP-IGF-I vs.
AgRP-Control: 1.09 ± 0.02 fold, n = 5 experiments per group, NS; Fig 4C and 4D). However,
GHRH neurons harvested from underfed GHRH-eGFP pups did not respond to IGF-I stimu-
lation (GHRH-IGF-I vs. GHRH-Control: 1.07 ± 0.01 fold, n = 4 experiments per group, NS;
Fig 4A and 4B), in contrast to normally fed pups (Fig 3A and 3B), and were only moderately
sensitive to the inhibition of the IGF-1R by OSI (GHRH-OSI vs. GHRH-Control: 0.84 ± 0.04
fold, n = 4 experiments per group, p< 0.05; Fig 4B). This moderate effect of OSI is probably
due to its supplementary inhibitory effect on the insulin signaling pathway that is crucial for
neuron survival, as explained above in experiments on normally fed mice. These data suggest
that GHRH neurons from underfed pups are insensitive to IGF-I despite normal culture
conditions.
Underfeeding alters the IGF-I signaling pathway
The main elements of the IGF-1R signaling pathway were measured by Western blot analysis,
despite the highly limited amount of protein that could be harvested from micro-dissected
arcuate nuclei from normally fed or underfed 7 day-old pups. As with explants cultures,
micro-dissected arcuate nuclei were harvested from both sexes. Overall, underfed pups had
similar IGF-1R protein levels in their arcuate nucleus as age-matched normally fed pups (Fig
5A and 5B right panel). In addition, a similar induction of IGF-1R activation (p-IGF-1R/IGF-
1R ratio) was observed after 15 min of IGF-I stimulation in both underfed and normally fed
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pups relative to the basal condition (Fig 5A and 5B, left panel). These data suggest that both
total IGF-1R levels and its activation were not altered by nutritional restriction.
We thus determined the activation capacities of the two principal signaling pathways acti-
vated by the IGF-1R, the PI3K/AKT, and the ERK/MEK pathways. The induction of activated
AKT (increase of the p-AKT/AKT ratio) following IGF-I stimulation was much lower in arcu-
ate nuclei isolated from underfed pups than those from normally fed pups (Fig 5A and 5C, left
panel). This impairment appeared to involve the activation of AKT as the level of total AKT
protein was similar for the two groups (Fig 5A and 5C, right panel). For the ERK/MEK path-
way, the induction of activated ERK-1 (increase of the p-ERK-1/ERK-1 ratio) by IGF-I stimu-
lation was not significantly modified in arcuate nuclei harvested from underfed pups relative
to normally fed pups (Fig 5A and 5D left panel, NS: p = 0.126). Total ERK-1 protein levels
were also not modified by nutritional restriction (Fig 5A and 5D, right panel). Induction of
activated ERK-2 (increase of the p-ERK-2/ERK-2 ratio) following IGF-1 stimulation was also
similar for underfed and normally fed pups (Fig 5A and 5E, left panel). However, total ERK-2
protein levels were elevated in underfed pups (Fig 5A and 5E, right panel). We observed
Fig 4. GHRH neurons from underfed pups do not respond to IGF-I stimulation. Illustrative micrograph of in vitro cultured explants of
arcuate nuclei of hypothalamus micro-dissected from 7 day-old underfed GHRH-eGFP+ pups of both sexes are shown (A) in basal
condition, under IGF-I stimulation or in presence of OSI-906 inhibitor (alone or in combination, with axons from whole arcuate (NF) and
GHRH neurons labeled by a dual-IHC for neurofilament (NF, top panels in red) and eGFP (GHRH-eGFP, lower panels in green),
respectively. Quantification of relative axon growth stimulated by IGF-I and/or its inhibitor OSI-906 (OSI) in 24 h for NF (plain bars) and
GHRH-eGFP (GHRH, dashed bars) are presented (B). In a separated set of experiment, a similar experiment was performed on NPY/
AgRP neurons labeled by IHC for AgRP (in orange) (C). The relative axon growth of this other subpopulation of arcuate neurons under
IGF-I stimulation and/or its inhibitor OSI-906 (OSI) is presented (D). Data are presented as the mean ± SEM calculated from n = 4 (B) and
5 (D) experiments per group (see results section for details). Results were compared using a two-way ANOVA analysis with the
Bonferonni post-test (B) or one-way ANOVA analysis with the Newman Keuls post-test (C). *: p < 0.05 and **: p < 0.01 for each
treatment vs. Control; δ: p < 0.05, and δδδ: p < 0.001 for each treatment vs. IGF-I.
doi:10.1371/journal.pone.0170083.g004
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similar results for the MEK protein as for the ERK-2 protein: a similar response of the under-
fed and normally fed pups to IGF-I stimulation (Fig 5A and 5F, left panel), and an elevated
level of total protein in underfed pups relative to normally fed pups (Fig 5A and 5F, right
panel). Altogether, these data suggest that the absence of axon elongation observed for GHRH
neurons in underfed pups is associated with impaired activation of the PI3K/AKT signaling
pathway, whereas the activation capacity of the ERK/MEK pathway is maintained.
The role of the PI3K/AKT and ERK/MEK signaling pathways in the regulation of axon out-
growth of GHRH neurons were further investigated in arcuate explants from both normally
and underfed pups, using specific IGF-1R signaling pathway inhibitors. Normalization respec-
tive to the basal conditions of these two sets of experiments (performed in 4 well plates)
required presenting the data on two separate graphs since basal axon growth in explants from
underfed pups is lower than that of normally fed pups. In agreement with the previous in vitro
results, co-stimulation of arcuate explants from normally fed pups with IGF-I and the specific
PI3K inhibitor LY294002 (LY) significantly inhibited IGF-1 mediated axon growth of GHRH
neurons relative to both basal conditions (GHRH-IGF/LY vs. GHRH-Control: 0.83 ± 0.03
fold; n = 4 experiments per group; p< 0.001; Fig 5G) and IGF-I alone (p< 0.001; Fig 5G).
Fig 5. Alterations of the IGF-IR signaling pathways in arcuate explants from underfed pups. Activation of key elements of IGF-1R
signaling pathways were measured by Western blot analysis as illustrated with representative blots in basal condition (-) or 15 min after
IGF-I stimulation (IGF-I) (A). Quantification indicates activation of the IGF-1R (fold induction of the p-IGF-1R/ IGF-1R ratio) by IGF-I
stimulation relative to basal levels (left panel), and total IGF-1R protein levels (right panel) in arcuate explants harvested from normally
fed and underfed pups of both sexes (B). Similarly, activation of AKT (fold induction of the pAKT/AKT ratio) (C), ERK1 (D), ERK2 (E) and
MEK-1 (F) are presented (left panels) with their respective total protein levels (right panels) (n = 4–6 per group). In vitro explant cultures
indicate that specific inhibition of PI3K by LY294002 (LY) and of MEK by PD0325901 (PD) impaired axon growth of GHRH neurons in
normally fed (n = 4 per group) (G) and underfed GHRH-eGFP+ pups (n = 6 per group) (H). All data are presented as the mean ± SEM
with Mann Whitney analysis for Western blot analysis with *: p < 0.05 (V-F); and one way-ANOVA analysis with the Newman Keuls post-
test (G, H) with *: p < 0.05 and ***: p < 0.001 for each treatment vs. Control; δδ: p < 0.01 and δδδ: p < 0.001 for each treatment vs. IGF-I;
Δ Δ Δ: p < 0.001 IGF-I/PD vs. IGF-I/LY.
doi:10.1371/journal.pone.0170083.g005
IGF-I Stimulates GHRH Neuron Axon Growth
PLOS ONE | DOI:10.1371/journal.pone.0170083 January 11, 2017 13 / 19
Treatment of explants with the specific MEK inhibitor PD0325901 (PD) also significantly
impaired axon growth of GHRH neurons in response to IGF-I stimulation (GHRH-IGF/PD:
vs. GHRH-IGF: p< 0.001; Fig 5G), but not relative to basal conditions (GHRH-IGF/PD vs.
GHRH-Control: 1.00 ± 0.03 fold; NS; Fig 5G). Thus, the inhibition of the PI3K signaling path-
way (LY) impaired IGF-1-mediated axon growth to a greater extent than inhibition of the
MEK pathway (PD) (GHRH-IGF/PD vs. GHRH-IGF/LY: p< 0.001; Fig 5G). This suggests
that IGF-I may stimulate axon growth of GHRH neurons in normally fed pups through the
PI3K/AKT and, to a lesser extent, the MEK/ERK signaling pathways.
Axon growth of GHRH neurons in explants from underfed mice was not stimulated by
IGF-1 and tended to be impaired by the inhibition of PI3K relative to basal conditions
(GHRH-IGF/LY vs. GHRH-Control: 0.88 ± 0.07 fold, n = 6 experiments per group; NS; Fig
5H), and IGF-1 treatment (GHRH-IGF/LY vs. GHRH-IGF: p < 0.01; Fig 5H). A similar pat-
tern was observed for inhibition of the MEK signaling pathway (GHRH-IGF/PD vs. GHRH-
Control: 0.83 ± 0.06 fold, n = 6 experiments per group; NS; Fig 5H). In contrast to normally
fed mice, neurons from underfed pups seemed to be equally sensitive to the inhibition of
both the PI3K/AKT and ERK/MEK signaling pathways (underfed: IGF/LY vs. IGF/PD: NS;
Fig 5H).
Discussion
Here, we show that IGF-I may be involved in axon elongation in a specific subpopulation of
hypothalamus neurons. Indeed, the present study indicates that i) IGF-I preferentially stimu-
lates axon growth of GHRH neurons in arcuate nucleus explants of normally fed pups during
lactation; ii) IGF-1 stimulation involves the two main signaling pathways PI3K/AKT and
ERK/MEK, with greater involvement of the PI3K/AKT pathway; and iii) GHRH neurons har-
vested from underfed pups during lactation and cultivated in vitro grow less and become
insensitive to the growth promoting effect of IGF-I. This loss of response does not involve an
alteration of the IGF-1R or ERK/MEK pathway, but is associated with a defect in AKT activa-
tion. Finally, iv) nutritional restriction during lactation, which is associated with permanent
growth retardation and later metabolic alterations, is associated with lower IGF-I plasma levels
and a change of the body growth trajectory. It is preceded by delayed axon elongation of
GHRH neurons during the first 10 days of life, a critical developmental window. These physio-
logical outcomes are in agreement with the tight control of IGF-I levels by nutritional supplies.
Prior studies have shown that they are sex and age differences in GHRH neuron develop-
ment [26]. Our explant experiments were carried out during a period in which there are sex-
dependent differences concerning GHRH neurons in the arcuate. Indeed, it was reported that
GHRH neurons increase in both sexes during the P1–P10 period, males having more GHRH
neurons than females. After P20, the number of GHRH neurons stabilized in males, and con-
tinued to increase in females [26]. Since a minimum amount of explants is required for the
quality of explants cultures, brain from both males and females were pooled before to be pro-
cessed. Although females may dampen the effects observed, arcuate nucleus explants were har-
vested from pups of both sexes to obtain a sufficient amount of material. Our study showed an
identical number of GHRH neurons in both normally fed and underfed male pups at P10 (Fig
2A) and highlights the positive effect of IGF-I on GHRH neuron axonal elongation, as shown
at P7. The potential sexual dimorphic effect of IGF-I on axon growth of GHRH neurons har-
vested specifically from male or female pups will require further studies.
IGF-I is well known to improve proliferation and cell survival in virtually all cellular models
tested. High IGF-I levels in the brain are associated with increased length and complexity of
neuronal dendritic arborization [12,13,14]. It is also strongly associated with axonal
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determination during the early phase of neuronal differentiation through plasmalemmal
expansion [17] induced by the IGF-1Rgc isoform [15,16]. During the later phase of neuronal
differentiation and axon elongation, IGF-I induces axonal outgrowth in some neuronal sub-
populations. However, this effect is not ubiquitous. Indeed, IGF-1R signaling is associated
with axon elongation of corticospinal motor neurons during development [19], but not in
adulthood [20]. In contrast, axon regeneration of raphespinal and cerulospinal axons after a
spinal cord injury in adults is stimulated by IGF-I [20], despite that corticospinal motor neu-
rons are in close proximity to the raphespinal and cerulospinal neurons [20]. These data sug-
gest that corticospinal motor neurons specifically lose their capacity to respond to IGF-I in
adult animals. IGF-1 also does not stimulate axon elongation in the developing lateral olfactory
neuron model, but appears to have chemotactic effects [18]. These data suggest that IGF-I may
stimulate axon elongation in a cell specific manner and a similar mechanism may operate in
the hypothalamus of mice during the early postnatal period. Indeed, IGF-I seems to preferen-
tially stimulate axon elongation of the GHRH neuronal subpopulation, highlighting the com-
plexity of the role of IGF-I in neuronal development.
The PI3K/AKT pathway is strongly implicated in the stimulation of axonal outgrowth in
normally fed pups, and underfeeding is associated with impaired AKT stimulation. The spe-
cific role of the two IGF-1R signaling pathways has been studied in different models of neuro-
nal cultures. Notably, the stimulation of axonal outgrowth by the PI3K/AKT signaling
pathway has been associated with perikaryon-independent plasmalemmal expansion in
embryonic pyramidal neurons of the hippocampus [15,17,35]. In contrast, the stimulation of
axonal outgrowth in sensory neurons by the ERK/MEK signaling pathway has been associated
with both local protein synthesis and the regulation of gene transcription [36,37]. Other stud-
ies suggest that both the PI3K/AKT and ERK/MEK signaling pathways present a potential cell-
type specific effect. Indeed, the ERK/MEK signaling pathway has been associated with
increased axon length in dorsal root ganglion neurons, whereas the PI3K/AKT pathway was
associated with axon caliber and branching [38]. Thus, the increase of ERK2 and MEK protein
levels in the arcuate of underfed pups may indicate compensation for the altered AKT activa-
tion. Further studies will be required to determine the role of the AKT signaling pathway in
GHRH axon growth in more details, and particularly if underfeeding is associated with alter-
ations of plasmalemmal expansion of GHRH neurons.
Our present study shows that nutrition plays a crucial role in the development of the
somatotropic axis of the hypothalamus-pituitary complex. These data are in agreement with
other studies that link nutrition during this critical period and the programming of various
hypothalamic neuronal network, notably those of subpopulations that regulate food intake
and metabolism in adults, and of the reproductive axis [33,34,39,40]. We previously observed
that IGF-1R heterozygous invalidation in the central nervous system specifically leads to a sim-
ilar postnatal growth defect in male mice [7]. Undernutrition is well known to decrease IGF-I
levels [41], and nutritional restriction during the lactating period may alter postnatal growth
through a decrease of IGF-I signaling. However, other hormones tightly controlled by nutri-
tion like leptin or insulin cannot be excluded as they were implicated in axonal development
of AgRP neurons of the arcuate nucleus [33,40]. Since IGF-1R is enriched in the terminal end
of growing GHRH axons, the IGF-1R signaling may be important for their elongation. In this
way we observed a stimulating effect of IGF-I on GHRH neurons axon growth preferentially.
Unfortunately, IGF-1R is virtually expressed by all cells and IGF-1R quantity cannot be easily
measured to explain this preferential effect of IGF-I on GHRH neurons, which remain to be
studied in details. Axonal growth of GHRH neurons appears to be a crucial physiological
mechanism, controlled by IGF-I, which programs the subsequent production of GH by the
pituitary gland, ultimately coordinating organ growth in an endocrine-dependent manner in
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response to environmental cues during the critical window of the early postnatal period.
Growth is indeed a highly integrated process and a tight evaluation of available resources is
required to adapt linear growth. The growth programming effect of IGF-I through the regula-
tion of axon growth of GHRH neurons may be one component. This mechanism is thus
important from the perspective of the predictive adaptive response hypothesis within the
DoHAD, because adult size determines the daily metabolic needs that must be adapted to a
predicted environment to optimize survival capacities and reproduction [1,3,4]. Ultimately,
this mechanism, accompanied by changes of perinatal IGF-I levels, may partially program age-
ing and longevity which are also partially controlled in mammals by GH/IGF-I signaling in
adulthood [6,7,42,43].
Supporting Information
S1 Fig. Nutritional Restriction does not alter the somatotropic axis in Females. (A) Body
weight gain during postnatal development is similar between normally fed (n = 17–22) and
underfed females (n = 23–25). Coherently, (B) plasma IGF-1 circulating levels (n = 10 per
group) and (C) GH mRNA levels in pituitary (n = 9 per group) at 3month of age are similare
between females that have been previously normally fed or underfed during lactation. More-
over, Nutritional restriction is not associated with a decrease of (D) plasma IGF-1 circulating
levels at 10 days of age (n = 6 and 4 per group, respectively) or (E) GHRH mRNA levels in
hypothalamus of 10 days old normally fed or underfed females (n = 10 and 9 per group,
respectively). Data are presented as the mean ± SEM. Gene expression determinations are nor-
malized against the histone H3 gene (C, E). Comparisons were performed by repeated measure
two-way ANOVA analysis (A) or Mann Whitney analysis (B–E).
(TIF)
S2 Fig. GHRH receptor and Pit-1 expression levels in adult male mice. (A) GHRH R
mRNA levels in pituitary of adult (3 month-old) male mice previously normally fed or under-
fed (n = 6 and 7 per group, respectively). (B) Pit-1 mRNA levels in pituirary of same animals
(n = 7 per group). Data are presented as the mean ± SEM. Gene expression determinations are
normalized against the histone H3 gene. Comparisons were performed with Mann Whitney
test.
(TIF)
S3 Fig. Nutritional Restriction is not associated with a decreased density of lactotroph cells
population in pituitary of 20 day-old male pups. Immunohistochemistry against prolactin
(PRL) (in red) and counterstained with DAPI (in blue) of pituitary harvested from 20 day-old
normally fed or underfed male pups in serial series of slices used for the GH mmunohisto-
chemistry (see Fig 1D) indicates that the density of lactotroph cells that produce PRL are not
decreased with underfeeding and even tend to increase (not significant). Representative micro-
graph are presented for normally fed (left panels) and underfed (midle panel), and the quanti-
fication is presented in the right panel. Data are presented as the mean ± SEM. Comparisons
were performed with a Mann Whitney analysis.
(TIF)
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